Li, Fei

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Li, F., Jiang, C., Krausz, K. W., Li, Y., Albert, I., Hao, H., Fabre, K. M., Mitchell, J. B., Patterson, A. D., & Gonzalez, F. J. (2013) · Nature Communications

Gut microbiota and healthDrug Transport and Resistance Mechanisms

Cited by 705

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Jiang, C., Xie, C., Li, F., Zhang, L., Nichols, R. G., Krausz, K. W., Cai, J., Qi, Y., Fang, Z.-Z., Takahashi, S., et al. (2015) · Journal of Clinical Investigation

Liver Disease Diagnosis and TreatmentGut microbiota and health

Cited by 693

Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice

Xu, Y., Li, F., Zalzala, M., Xu, J., Gonzalez, F. J., Adorini, L., Lee, Y., Yin, L., & Zhang, Y. (2016) · Hepatology

Cholesterol and Lipid MetabolismDrug Transport and Resistance Mechanisms

Cited by 172

Stable Isotope- and Mass Spectrometry-based Metabolomics as Tools in Drug Metabolism: A Study Expanding Tempol Pharmacology

Li, F., Pang, X., Krausz, K. W., Jiang, C., Chen, C., Cook, J. A., Krishna, M. C., Mitchell, J. B., Gonzalez, F. J., & Patterson, A. D. (2013) · Journal of Proteome Research

Metabolomics and Mass Spectrometry StudiesPharmacogenetics and Drug Metabolism

Cited by 31

Association between childhood trauma and risk for obesity: a putative neurocognitive developmental pathway

Luo, Q., Zhang, L., Huang, C.-C., Zheng, Y., Kanen, J. W., Zhao, Q., Yao, Y., Quinlan, E. B., Jia, T., Banaschewski, T., et al. (2020) · BMC Medicine

Child Abuse and TraumaEating Disorders and Behaviors

Cited by 26